These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 25110202)

  • 1. Can hepatitis C be eradicated in the United States?
    Edlin BR; Winkelstein ER
    Antiviral Res; 2014 Oct; 110():79-93. PubMed ID: 25110202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?
    Grebely J; Dore GJ; Morin S; Rockstroh JK; Klein MB
    J Int AIDS Soc; 2017 Jul; 20(1):22146. PubMed ID: 28782335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis c and human rights: comparison of legal experience of Ukraine and Georgia.
    Senyuta IY
    Wiad Lek; 2018; 71(2 pt 2):383-388. PubMed ID: 29786590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.
    Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J
    Int J Drug Policy; 2019 Apr; 66():87-93. PubMed ID: 30743093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A path to eradication of hepatitis C in low- and middle-income countries.
    Graham CS; Swan T
    Antiviral Res; 2015 Jul; 119():89-96. PubMed ID: 25615583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized US Efforts to Eliminate Hepatitis C.
    Gaudino A; Gay B; Garmon C; Selick M; Vreeland R; Burk K; Huriaux E; Facente SN; Luetkemeyer A; Waters P; Graham CS
    Infect Dis Clin North Am; 2018 Jun; 32(2):293-311. PubMed ID: 29778257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.
    Perlman DC; Jordan AE; Uuskula A; Huong DT; Masson CL; Schackman BR; Des Jarlais DC
    Int J Drug Policy; 2015 Nov; 26(11):1056-63. PubMed ID: 26050614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.
    Day E; Hellard M; Treloar C; Bruneau J; Martin NK; Øvrehus A; Dalgard O; Lloyd A; Dillon J; Hickman M; Byrne J; Litwin A; Maticic M; Bruggmann P; Midgard H; Norton B; Trooskin S; Lazarus JV; Grebely J;
    Liver Int; 2019 Jan; 39(1):20-30. PubMed ID: 30157316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five Questions Concerning Managing Hepatitis C in the Justice System: Finding Practical Solutions for Hepatitis C Virus Elimination.
    Spaulding AC; Adee MG; Lawrence RT; Chhatwal J; von Oehsen W
    Infect Dis Clin North Am; 2018 Jun; 32(2):323-345. PubMed ID: 29778259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can hepatitis C virus infection be eradicated in people who inject drugs?
    Grebely J; Dore GJ
    Antiviral Res; 2014 Apr; 104():62-72. PubMed ID: 24468275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus prevention, care, and treatment: from policy to practice.
    Ward JW; Valdiserri RO; Koh HK
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S58-63. PubMed ID: 22715216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs.
    Martinello M; Dore GJ; Matthews GV; Grebely J
    Infect Dis Clin North Am; 2018 Jun; 32(2):371-393. PubMed ID: 29778261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all.
    Grebely J; Hajarizadeh B; Lazarus JV; Bruneau J; Treloar C;
    Int J Drug Policy; 2019 Oct; 72():1-10. PubMed ID: 31345644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward the elimination of hepatitis C in the United States.
    Saab S; Le L; Saggi S; Sundaram V; Tong MJ
    Hepatology; 2018 Jun; 67(6):2449-2459. PubMed ID: 29181853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradicating hepatitis C: The need for a public health response.
    Wallace J; Richmond J; Ellard J; Power J; Lucke J
    Glob Public Health; 2018 Sep; 13(9):1254-1264. PubMed ID: 30012072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Virus.
    Kaplan DE
    Ann Intern Med; 2020 Sep; 173(5):ITC33-ITC48. PubMed ID: 32866406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment as prevention and cure towards global eradication of hepatitis C virus.
    Hagan LM; Wolpe PR; Schinazi RF
    Trends Microbiol; 2013 Dec; 21(12):625-33. PubMed ID: 24238778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework.
    Akiyama MJ; Kronfli N; Cabezas J; Sheehan Y; Thurairajah PH; Lines R; Lloyd AR;
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):391-400. PubMed ID: 33857445
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.